HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Henri Bourhis Selected Research

Multiple Myeloma

1/2013Dissociated responses to newer antimyeloma drugs identify a subset of refractory patients with an extremely poor prognosis.
4/2012Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
11/2006Maintenance therapy with thalidomide improves survival in patients with multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Henri Bourhis Research Topics

Disease

17Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 08/2003
10Leukemia
01/2020 - 06/2007
8Neoplasms (Cancer)
01/2019 - 08/2007
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019 - 03/2015
3Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 03/2004
3Pathologic Complete Response
11/2018 - 05/2008
3Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2018 - 07/2004
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2016 - 07/2006
3Philadelphia Chromosome
06/2015 - 10/2002
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2015 - 10/2002
3Multiple Myeloma
01/2013 - 11/2006
2Chromosome Aberrations (Chromosome Abnormalities)
01/2020 - 07/2003
2Graft vs Host Disease (Graft-Versus-Host Disease)
12/2018 - 01/2018
2Hodgkin Disease (Hodgkin's Disease)
11/2018 - 09/2013
2Lymphoma (Lymphomas)
01/2018 - 05/2007
1Infections
01/2021
1Body Weight (Weight, Body)
01/2020
1Hematologic Diseases (Blood Diseases)
01/2019
1Yellow Fever
01/2018
1Microsporidiosis
01/2017
1Neutropenia
07/2015
1Progressive Multifocal Leukoencephalopathy
09/2014
1Lymphopenia (Lymphocytopenia)
09/2014
1Blast Crisis (Blast Phase)
11/2013
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
05/2013
1Plasmacytoma
01/2013
1Myeloid Leukemia (Leukemia, Myelocytic)
07/2006
1Multi-centric Castleman's Disease
12/2003
1Amyloidosis
12/2003
1Bronchiolitis Obliterans Syndrome
11/2002
1Residual Neoplasm
10/2002

Drug/Important Bio-Agent (IBA)

3Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2021 - 01/2018
3Tyrosine Kinase InhibitorsIBA
06/2016 - 11/2013
2Busulfan (Busulfex)FDA Link
11/2018 - 11/2016
2Clofarabine (Clolar)FDA Link
11/2018 - 11/2016
2Daunorubicin (Cerubidine)FDA LinkGeneric
12/2015 - 02/2010
2AnthracyclinesIBA
12/2015 - 02/2010
2Cytarabine (Cytosar-U)FDA LinkGeneric
08/2011 - 02/2010
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2021
1Core Binding Factors (Core-Binding Factor)IBA
01/2020
1Calcineurin InhibitorsIBA
12/2018
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2018
1Carmustine (FIVB)FDA Link
11/2018
1Melphalan (Alkeran)FDA LinkGeneric
11/2018
1Etoposide (VP 16)FDA LinkGeneric
11/2018
1AntibodiesIBA
01/2018
1fumagillinIBA
01/2017
1fludarabineIBA
11/2016
1Pharmaceutical PreparationsIBA
12/2015
1Anti-Bacterial Agents (Antibiotics)IBA
07/2015
1Interleukin-7 (Interleukin 7)IBA
09/2014
1Azacitidine (5 Azacytidine)FDA Link
11/2013
1IPH-2101IBA
11/2012
1KIR ReceptorsIBA
11/2012
1trans-sodium crocetinate (crocetin)IBA
08/2011
1Interleukin-2 (IL2)IBA
02/2010
1Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
02/2010
1Rituximab (Mabthera)FDA Link
05/2007
1Thalidomide (Thalomid)FDA Link
11/2006
1Oncogene Proteins (Oncogene Protein)IBA
07/2006
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2006
1galactomannanIBA
03/2004
1Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
03/2004
1AntigensIBA
03/2004
1Monoclonal AntibodiesIBA
12/2003
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2002

Therapy/Procedure

19Therapeutics
01/2020 - 10/2002
18Stem Cell Transplantation
01/2021 - 10/2002
8Drug Therapy (Chemotherapy)
12/2020 - 12/2003
7Transplantation
01/2021 - 11/2002
7Hematopoietic Stem Cell Transplantation
01/2021 - 05/2008
5Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2020 - 09/2013
4Cell Transplantation
01/2021 - 01/2019
2Autologous Transplantation
01/2020 - 08/2007
2Homologous Transplantation
01/2018 - 04/2012
2Induction Chemotherapy
02/2010 - 06/2007
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
03/2015
1Remission Induction
02/2010